3 May 2022 09:03
RNS Number : 0830K
TClarke PLC
03 May 2022
TClarke plc("the Company")
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
The Company announces that Aysegul Sabanci, Non Executive Director of the Company, has advised the Company that she purchased 2,000 ordinary shares of 10p each in the Company at 148.50p per share on Tuesday 3rd May 2022.
Formal notification in respect of the purchase is below; 1 | Details of the person discharging managerial responsibilities / person closely associated | a) | Name | Aysegul Sabanci | 2 | Reason for the notification | a) | Position/status | Non Executive Director. | b) | Initial notification/Amendment | Initial notification | 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | a) | Name | TClarke plc | b) | LEI | 213800OIP8MU517BK123 | 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 10 pence each GB0002015021 | b) | Nature of the transaction | Market purchase of shares | c) | Price(s) and volume(s) | Price(s) | Volume(s) | 148.50 pence | 2,000 |
| d) | Aggregated information - Aggregated volume - Price | N/A (single transaction) | e) | Date of the transaction | 2022-05-03 | f) | Place of the transaction | XLON - London Stock Exchange |
For further information contact: TClarke plc Mark Lawrence - Group Chief Executive Trevor Mitchell - Finance Director Tel: 020 7997 7400 www.tclarke.co.uk Cenkos Securities plc (Corporate Broker) Ben Jeynes (Corporate Finance) Alex Potten (Sales) Tel: 020 7397 8900 www.cenkos.com RMS Partners Simon Courtenay Tel: 020 3735 6551 |
|
3rd May 2022
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHGZGGKRFGGZZG
Last checked at